Zentalis Pharmaceuticals
ZNTL
ZNTL
139 hedge funds and large institutions have $3.58B invested in Zentalis Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 38 funds opening new positions, 53 increasing their positions, 33 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
32% more capital invested
Capital invested by funds: $2.71B → $3.58B (+$865M)
20% more funds holding
Funds holding: 116 → 139 (+23)
3.31% more ownership
Funds ownership: 91.57% → 94.88% (+3.3%)
Holders
139
Holding in Top 10
6
Calls
$10.9M
Puts
$1.51M
Top Buyers
| 1 | +$54.8M | |
| 2 | +$36.2M | |
| 3 | +$31M | |
| 4 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$18.6M |
| 5 |
Holocene Advisors
New York
|
+$16M |
Top Sellers
| 1 | -$42.3M | |
| 2 | -$30.7M | |
| 3 | -$25.9M | |
| 4 |
Two Sigma Investments
New York
|
-$12.2M |
| 5 |
WP
Woodline Partners
San Francisco,
California
|
-$11.7M |